Literature DB >> 1086063

Differentiation of a methylcholanthrene-induced sarcoma to a benign plexiform fibroneural tumor in an adult frog (Rana pipiens). Possible influence of host regenerative capacity.

H C Outzen, R P Custer.   

Abstract

A spindle cell sarcoma appeared 20 months after implantation of a pellet of 3-methylcholanthrene in the denervated foreleg of an adult frog, Rana pipiens. Its growth rate and cellular structure were observed over the subsequent 19 months, the former remaining constant for the first 14 months, then slackening markedly during the final 4 months. Serial biopsies disclosed maturation to a well-differentiated fibroneural tumor of benign appearance, the change taking place notably during the period of decelerated growth rate. An autotransplant of the tumor to the hind leg adopted the same growth pattern and maturation. Possible causes for this behavior are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086063      PMCID: PMC2032550     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  4 in total

1.  IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.

Authors:  J B BECKWITH; E V PERRIN
Journal:  Am J Pathol       Date:  1963-12       Impact factor: 4.307

2.  Teratocarcinoma: model for a developmental concept of cancer.

Authors:  G B Pierce
Journal:  Curr Top Dev Biol       Date:  1967       Impact factor: 4.897

Review 3.  Chemical carcinogenesis.

Authors:  H J Ryser
Journal:  N Engl J Med       Date:  1971-09-23       Impact factor: 91.245

4.  Response of murine cutaneous nerves to skin painting with methylcholanthrene.

Authors:  M J Fitzgerald; S M Lavelle
Journal:  Anat Rec       Date:  1966-03
  4 in total
  1 in total

1.  Humane anesthesia and pain management in amphibian limb surgery of Rana pipiens.

Authors:  Punita Koustubhan; David L Kaplan; Michael Levin
Journal:  Cold Spring Harb Protoc       Date:  2013-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.